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Abstract 
 
 
Introduction: There is no differentiation between primary spontaneous pneumothorax (PSP) 
and secondary pneumothorax (SP) in the current version of the International Classification of 
Diseases (ICD-10).  Objective: To validate the accuracy of an algorithm that identifies cases 
of PSP from administrative databases.  Methods: The charts of 150 patients who attended the 
emergency room (ER) with a recorded main diagnosis of pneumothorax were reviewed.  The 
corresponding hospital administrative data collected during previous hospitalizations and ER 
visits were processed through the proposed algorithm.  The results were compared over two 
different age groups.  Results: The results obtained from the PSP algorithm demonstrated a 
significantly higher sensitivity (97% vs. 81%, p=0.038) and positive predictive value (87% 
vs. 46%, p<0.001) in patients under 40 years of age compared to older patients.  Conclusions: 
The proposed algorithm is adequate to identify cases of PSP from administrative databases in 
the age group classically associated to the disease.  
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1 Introduction 
 
1.1 Background and Overview 
Primary spontaneous pneumothorax (PSP) is one of the most common lung diseases 
treated by thoracic surgeons. It is a medical condition affecting generally young and 
healthy individuals who are presenting with sudden onset shortness of breath and 
shoulder pain. It results from the rupture of a lung bulla, a pocket of air located at the 
superior portion of the lung, leading to the accumulation of intrathoracic atmospheric air 
and collapsing the lung at some degree. Spontaneous pneumothorax can also occur in 
patients presenting different types of lung diseases such as lung emphysema or cystic 
fibrosis, which will impact the long-term management. While PSP is most commonly a 
benign condition that can sometimes simply be observed, it has the potential, if 
unrecognized, to progress to a catastrophic situation in which the heart and other intra-
thoracic organs are compressed by a high pressure tension pneumothorax potentially 
creating a hemodynamic instability, which if untreated can be fatal. 
 Depending on the size of the pneumothorax and its associated clinical presentation, the 
initial management may vary.  It may include simple observation, needle aspiration, or 
chest drainage allowing an evacuation of the intrathoracic trapped air until the lung 
breach has healed. But sometimes, a persistent air leak from the lung originating from a 
“broncho-pleural fistula” will need to be addressed surgically. This is one of the 
indications to perform a surgical intervention for PSP in which the bullae of the lung are 
removed and the lung defect is being closed. It is normally associated to another 
procedure, named pleurodesis, that can be either mechanical or chemical and that aims to 
induce the formation of scar tissue within the chest cavity to permanently maintain the 
lung surface adherent against the inner portion of the chest wall, which will decrease the 
chance of another episode. 
However, the main indication to perform surgery for PSP is to prevent recurrence. Many 
factors have been proposed to increase the risk of recurrence in patients following an 
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episode of PSP, but the most important is the number of prior PSP episodes. Most 
patients will be offered surgery after a second documented episode. 
Unfortunately, the exact risk of recurrence following an episode of PSP is hard to predict, 
in part because only few studies with a limited number of patients have been conducted 
specifically on the subject. Some population-based studies are available but include both 
primary and secondary spontaneous pneumothorax which are often pooled under the 
same classification codes in hospital discharge summaries. This is problematic, as the 
recurrence risk, and the factors influencing recurrence, may be different among 
secondary pneumothorax. Large administrative data studies specifically on PSP are 
lacking. 
Administrative hospital data are potentially powerful data sources, allowing 
epidemiological studies of diseases, but the accuracy of the data must be confirmed. The 
tenth edition of the International Classification of Diseases (ICD-10-CA) was introduced 
in Canada in 2000, and it includes codes allowing the identification of patients seeking 
medical treatment for pneumothorax. A subdivision of the code J93 further differentiates 
between spontaneous tension pneumothorax, other spontaneous pneumothorax, other 
pneumothorax, and pneumothorax (unspecified). Unfortunately, the classification does 
not clearly allow the identification of PSP, which would be necessary for the conduct of 
large population-based studies on PSP using administrative data from emergency room 
visits and hospital discharge summaries.  
The clinical significance of this lack of knowledge on PSP is that it might be difficult for 
a physician to predict the risk of recurrence of a particular patient and therefore decide 
which treatment would be the most appropriate. 
The objective of this work is to validate the accuracy of an administrative data algorithm 
designed to identify PSP cases from the recorded emergency room and hospital discharge 
summaries, in order to allow population-based research in this population. 
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2. Literature review 
 
2.1 Definition and incidence of primary spontaneous 
pneumothorax 
The accumulation of air into the pleural cavity, or pneumothorax, can happen suddenly in 
previously asymptomatic individuals. The term secondary pneumothorax (SP) has been 
used to define this condition when it is caused by an underlying medical condition, such 
as emphysema or trauma. It is different than primary spontaneous pneumothorax, which 
is occurring mainly in previously healthy patients.1 It is the result of the rupture of blebs 
or bullae located at the apex of the lung, or by the presence of pleural porosities in this 
area.2 Melton et al. reported 77 cases of PSP occurring over a 24-year period in Olmstead 
county, Minnesota and calculated an age-adjusted incidence rate of 7.4/100 000 persons 
per year in males and 1.2/100 000 persons per year in females (adjusted for the USA 
white population age distribution from 1960). The phenomenon was described as being 
6.2 times more frequent in males than in females.3 Others have reported incidence rates 
varying between 18-28 cases/100 000 persons per year for males and between 1.2-6 
cases/100 000 persons per year for females.4 The peak of incidence is believed to be 
between the age of 20 and 30 years-old.5 More recently, an analysis of a French database 
identified over a 4-years period, 42595 patients requiring hospitalization for either  
primary and secondary pneumothorax and calculated an annual incidence rate of 22.7 
cases/100 000 persons.6 
 
2.2 Clinical presentation and management 
Patients presenting an acute episode of pneumothorax will complain most commonly of 
dyspnea and severe chest pain irradiating to the shoulder. The physical examination will 
reveal decreased breath sounds on auscultation and hyperresonance at chest percussion of 
the involved side. A postero-anterior chest radiography will confirm the diagnosis and 
will allow an estimation of the pneumothorax size. (Figure 1.)  
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Figure 1. Postero-anterior chest radiograph documenting a complete right-sided 
pneumothorax with shifting of the mediastinum towards the left chest. The right 
lung is completely collapsed (arrow) creating a large intrapleural space filled with 
air in which the normal aspect of lung parenchyma and vasculature is no longer 
visible. 
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Depending on the severity of the clinical symptoms and the size of the pneumothorax, 
most patients with will be treated by simple observation, needle aspiration or chest-tube 
insertion. Although the clinical course of most patients will be benign, PSP might have 
occasionally serious complications. In some cases a tension pneumothorax might 
develop. This is a life-threatening condition caused by the accumulation of air under 
pressure within the chest, from a one-way valve phenomenon at the site of the air leak.7 
Increased thoracic pressure, shifted mediastinal structured and a compromised blood 
return to the right atrium may lead to hypoxia, hypotension and cardiovascular collapse.8 
Another reported complication from PSP is persistent air leakage from a broncho-pleural 
fistula, which may result in a prolonged hospital stay. In these cases the site of rupture at 
the apex of the lung will not heal for many days and the patient will require chest tube 
insertion to evacuate the air from the pleural cavity, a procedure usually associated with 
minimal complications, however pain or discomfort might be significant. Sometime, a 
larger  broncho-pleural fistula will lead to air accumulating within the chest despite 
previous drainage and additional chest tube insertion, or suction chest drainage is 
necessary.9 (Figure 2.) A prolonged air leak will be an indication to address PSP by 
surgery. Although there is no consensus on the most appropriate length of time to wait 
until the leak stops before proceeding with a surgical intervention, most experts will 
recommend a waiting period of 5 days.4 
Surgical procedures for PSP are some of the most commonly performed interventions in 
thoracic surgery and are usually definitive. Through an open axillary approach or with the 
use of thoracoscopy, the procedure includes the removal of the apical blebs and bullae 
which are thought to be causal factors. In addition, in order to improve the surgical 
results and minimize the potential for recurrence, some type of pleurodesis will be 
performed to promote scarring at the apex of the lung, which will adhere to the inner 
surface of the thoracic cavity. Mechanical pleurodesis includes pleural abrasion or 
pleurectomy and can only be performed at the time of surgery. A chemical pleurodesis 
might be performed at the time of surgery, but also in the endoscopy unit during medical 
thoracoscopy, or even at the patient`s bedside by the injection of sclerosing agents 
through chest tubes.10 This latter approach was shown to be inferior to a surgical 
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approach, but can be a valid option in frail patients who aren`t candidates for a surgical 
intervention.11  
 
Figure 2. An incomplete re-expansion of the right lung can be seen on this chest 
radiograph following the insertion of a drainage catheter for a spontaneous 
pneumothorax (white arrow).  A discrete amount of subcutaneous emphysema is 
also visible in the subcutaneous tissues around the site of chest tube insertion (black 
arrow). 
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Several products have been suggested as potential sclerosing agents to use in cases of 
PSP, the most effective being talc, which can be directly insufflated within the chest or 
injected as a suspension into the chest tube. Chemical pleurodesis is rarely used alone in 
patients with PSP in Canada and in the United States, but many European authors have 
suggested that this could represent an adequate alternative to surgery and that the 
resection of the causative ruptured blebs or bullae could be optional.12 Pain and talc 
toxicity (including acute pneumonitis, acute renal failure and myocardial infarction) have 
been described as potential adverse events of talc pleurodesis.13 
As previously mentioned, surgical intervention might be necessary in cases of prolonged 
air-leak. In those cases, the procedure will allow to stop the air-leakage and withdraw the 
drainage catheter, to eventually discharge the patient from the hospital. (Figure 3.)  In 
those cases, the necessity of the procedure is obvious. Similarly, an intervention to 
prevent PSP recurrence is recommended in certain hazardous situations, such as when a 
patient is living far away from accessible medical care, working in pressurized 
environment (e.g. airplane pilot, divers) and when a pneumothorax recurrence can 
become a catastrophic situation.14 
Outside of those obvious conditions, surgery for pneumothorax is most commonly aimed 
at recurrence prevention. The problem is that this risk of recurrence in a specific patient is 
difficult to define. As detailed by Massard et al., the risk of recurrence increases after 
each new episode of pneumothorax, and patients presenting with recurring PSP, either 
ipsilateral or contralateral, should be offered surgery.8 This has become a generally well 
accepted concept, even considering the paucity of information on this subject in the 
medical literature. In a Delphi consensus statement on the management of pneumothorax 
by the American College of Chest Physicians, 85% of the expert panel members 
recommended surgery after the first recurrence of PSP. The number of previous episodes 
is the only predictor of recurrence commonly used in clinical practice.15 
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Figure 3. Following surgery for primary spontaneous pneumothorax with persistent 
air leak, the expanded right lung occupies the totality of the ipsilateral pleural 
space. This chest radiograph documents the presence of a chest tube and close to its 
tip postoperative changes of the apex of the lung related to bullectomy.  
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2.3 Reported PSP recurrence rates 
Because of the fact that recurrences seem to guide the treatment offered to patients 
suffering from PSP, one would expect to find in the medical literature a thorough  
description of this risk  and of the different factors modelling it. But this is not the case: a 
wide variation in the recurrence rates have been described, ranging from 10 to 21% after 
a first episode, and rising as high as 50% to almost 80% after a second and third episode.8 
The time interval during which the recurrences were captured varies from one study to 
the other, offering generally a short period of follow up, and reporting a wide variety of 
incidence of this late complication. In their article published in 1991, Lippert et al. were 
the first to report appropriately the results on a time-related basis.16  Their 5-year 
cumulative survival without pneumothorax in patients without lung disease was estimated 
to be 77% (95% confidence interval: 73-81%). Many authors cited the information 
published by Cran and Rumball reporting data collected on spontaneous pneumothorax in 
the British Royal Air Force between 1941 and 1962, on 994 men aged between 16 and 50 
years-old.17 A global recurrence rate of 18.7% was described, with most recurrences 
occurring within one year (59.5%) or two years (81.0%) after the first episode. The 
proportion of spontaneous pneumothorax recurrences occurring after five years was 
minimal (3.2%). In a recent study from Korea, 232 patients were treated without surgery 
and underwent telephone follow up for 4 to 8 years following their episode of PSP. The 
number of PSP episodes was not included in the analysis, but a recurrence rate of 29% 
was noted in patients treated with observation. The patients who required chest drainage 
had a 54% recurrence rate, which is higher than what has been reported before.18 
 
2.4 Risk factors for pneumothorax  
Many clinical elements have been described as potential risk factors for the development 
of a first episode of PSP. It is important to understand those characteristics as they could 
also cause recurrence. This was suggested in a review of 1491 patients who presented 
themselves in 14 medical centers in France over a period of 4 years, where no differences 
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in clinical factors could be identified between initial and recurrent cases.19  The most 
commonly cited patient-related risk factor is gender. Males are known to be more than 
three times more at risk than females to develop a pneumothorax, and this risk rises up to 
six times when the analysis is restricted to PSP.3,6 Age is also related to the risk of 
developing PSP. In a review from the General Practice Research Database (GPRD) 
including 5.6% of the patients treated in England and Wales, Gupta et al. described a 
biphasic distribution of age in patients consulting for any pneumothorax. The first peak of 
incidence was thought to be mainly due to PSP and was corresponding to the 20-24y.o. 
age group in male and 30-34y.o. age group in female.5   Another risk factor for a 
spontaneous pneumothorax is smoking. In a population-based study in the county of 
Stockholm, Sweden, Bense et al. reported in 1987 a 9-fold and 22-fold risk increase of 
developing pneumothorax with tobacco smoking in women and men, respectively.20 
Marijuana smoking has also been identified as detrimental for respiratory functions and it 
is suspected to increase even more the risk of developing bullous lung diseases and 
causing pneumothorax in individuals who are most commonly already smokers.21 Tall 
and thin individuals are known to be at higher risk for PSP. The effect of the height-
weight ratio on the risk of recurrence has been confirmed by Nakamura to be independent 
from the effect of the level of tobacco consumption.22 Patients height seems to be a more 
important factor than weight for the occurrence of PSP, taller individuals being at higher 
risk.23 Rapid changes in the configuration of the upper chest occurring during 
adolescence was found to have an impact on the risk of developing PSP in a case-control 
study on 404 patients treated in Taiwan.24 The intensity of physical activity was initially 
suspected as being a significant etiological factor for PSP, but this has been refuted.4 
Some psychological or emotional factors were once suspected to cause PSP. In an 
interesting cooperative work involving departments of psychiatry and emergency 
medicine, no clear relation could be identified between episodes of PSP and patients’ 
anger, anxiety or depression levels.25 Certain environmental factors, such as weather 
conditions, atmospheric pressure, level of air pollution, have been suggested to promote 
the occurrence of PSP. 26-29 However, in the study of 638 pneumothorax patients admitted 
over a period of 4 years in a French urban area of 110 000 inhabitants, no relation could 
14 
 
be identified between the occurring of pneumothorax and atmospheric pressure, relative 
humidity, rainfall, wind speed or temperature.30  
 
2.5 Risk factors for PSP recurrence 
It is unusual for patients to develop PSP recurrence following surgical treatment, unless 
an incomplete bullae resection is performed with an inadequate pleurodesis. (Figure 4.) 
Many reports in literature have defined the factors related to those unsuccessful 
interventions, however it was decided for this work not to include them and to limit the 
review to the natural history of PSP prior to any definitive treatment.  
The presence of air trapping on tomodensitometry (CT-Scan), has been described as 
being a risk factor for PSP.31  In a study on 176 patients treated without surgery and 
followed for at least 12 months after an episode of PSP, the risk of recurrence increased 
from 6% to 68% in patients found to have blebs or bullae on high-resolution CT-scan.32 
Similarly, in a retrospective study of 114 patients treated non-surgically for PSP, Young 
Choi et al. noted after a mean follow up of 43 months a recurrence rate higher (60% vs 
31%) in patients documented to have blebs or bullae identified on high-resolution CT-
scan. In a retrospective review of 153 patients treated for PSP, Sadikot et al. reported 
over a four-year period a 54.2% rate of recurrence. Gender, height and smoking status 
were the only three independent factors for recurrence that could be found as 
significant.33  Similarly, in a study of 122 subjects treated for a first episode of 
spontaneous pneumothorax, Lippert et al. documented a higher risk of recurrence in 
patients with lower height-weight ratio, in smokers, in patients over 60 years of age and 
in patients presenting pulmonary fibrosis on chest X-Ray. This study however included 
patients who underwent surgical treatment for pneumothorax and possibly also cases of 
secondary pneumothorax, making the results from their analysis not applicable to non-
surgical PSP cases.16 
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Figure 4. Coronal view of the chest computed tomodensitometry performed in a 
patient presenting a left PSP recurrence 18 month following ipsilateral axillary 
thoracotomy for bullectomy with vibramycin pleurodesis. A residual bulla can be 
seen next to the stapler line (arrow). In this case, the absence of adhesion between 
the lung and the chest wall was suspected to be secondary to the weak efficacy of the 
antibiotic as agent for pleurodesis.  
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The patient BMI seems to be related to the risk of recurrence. In a retrospective analysis 
of a cohort of 273 patients aged less than 30 years and treated for a first episode of PSP, 
Tan et al. recorded 81 recurrences (30%). Sixty-four percent of their patients underwent 
surgery. They performed a Cox regression analysis and identified 3 factors associated to 
recurrence: a low body-mass index (BMI) (less than 18.5 kg/m2), the absence of surgical 
treatment, and a large-size pneumothorax (more than 50% of the lung volume).34 In a 
similar study design including 553 patients treated surgically for PSP and analyzing the 
risk factor for contralateral recurrence, Chen et al. identified both low BMI and visible 
blebs/bullae on HDCT to be related to an additional episode of PSP.35 Another group 
from China (Chiu et al.), analyzing the results of 128 patients treated medically for a first 
episode of pneumothorax, identified the size of the pneumothorax to be associated to 
further episodes.36 
Other factors related to the type of treatment offered to patients with PSP have been 
related to the risk of recurrence. The decision to treat the patient initially with chest air 
aspiration through thoracentesis instead of chest tube insertion was found to have a 
higher incidence of recurrence during the first week of follow-up in two studies published 
in the mid-1990’s.37  This finding is however not surprising because multiple 
thoracentesis sessions may be necessary when this procedure, most commonly performed 
in Europe, is used when dealing with PSP.38 In a meta-analysis of randomized trials 
comparing the results of thoracentesis and chest drainage in the treatment of PSP, no 
significant difference could be identified in recurrence rates at one year.39 The 
performance of chemical pleurodesis through the chest-tube at the moment of initial 
treatment for PSP has been shown to be an effective way to reduce recurrences, and 
reports have detailed the benefits of using tetracycline, minocycline or talc suspension to 
obtain an effective sclerotherapy of the pleural space.40,41  
 
2.6 Pneumothorax in administrative data studies 
Administrative hospital data are potentially powerful data sources, allowing 
epidemiological studies of diseases, but the accuracy of the data must be confirmed.  The 
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tenth edition of the International Classification of Diseases (ICD-10-CA) was introduced 
in Canada in 2000, and implemented in Ontario in 2002. It includes codes allowing the 
identification of patients seeking medical treatment for pneumothorax.42  A subdivision 
of the code J93 further differentiates between spontaneous tension pneumothorax, other 
spontaneous pneumothorax, other pneumothorax, and pneumothorax (unspecified).43  
Unfortunately, the classification does not clearly allow the identification of PSP, which is 
necessary to conduct large population-based studies on the subject using administrative 
data from emergency room visits and hospital discharge summaries. 
Gupta et al. published in 2000 their work on the epidemiology of pneumothorax in 
England. They identified from the General Practice Research Database and the Hospital 
Episode Statistics obtained from the Office for National Statistics over 20,000 
consultations for pneumothorax between the years 1991 and 1995. The authors could not 
specifically target the patients presenting for PSP and included in their study patients 
treated for secondary pneumothorax and traumatic or iatrogenic pneumothorax. They 
were however able to demonstrate the impact of age on the incidence of pneumothorax, 
as both in males and females a biphasic distribution of cases of pneumothorax. The first 
peak of incidental cases occurred between ages 20-24 in males and between the ages 30-
34 in female. It was suggested that these early age pneumothorax were representing 
mostly PSP cases. 
In another population-based study, Bobbio et al, reported from the French database 
“Programme de Médicalisation des Systèmes d’Information” between 2008 and 2011, 59 
637 hospitalizations of 42 595 patients for pneumothorax. Patients treated as outpatients 
were not included in the study. The authors calculated an annual incidence of 22.7 cases 
per 100,000 population for France. The mean hospital stay was 7 days, 24% of patients 
underwent surgery with thoracoscopic resection of blebs (76% or intervention) associated 
to mechanical pleurodesis in 52% and talc pleurodesis in 24%. The authors excluded 
traumatic pneumothorax and differentiated between secondary pneumothorax and what 
was termed “idiopathic pneumothorax”. The authors used the ICD classification for the 
diagnosis of pneumothorax and it is unclear how they differentiated between idiopathic 
and secondary pneumothorax. The risk of recurrence could not be calculated in this 
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study, however, a high proportion of the cases represented a re-hospitalization, (48% of 
the cases in females and 49% of the cases in males), and in those cases the patients were 
found to be significantly younger (35 vs 40 years when no previous pneumothorax could 
be documented), and underwent more often a surgical procedure. There was in this study 
a high proportion of idiopathic pneumothorax (85% of patients) even in the group of 
patients above 50 years old (65% of cases in males and 77% in females). This raises the 
question whether or not the idiopathic pneumothorax cases in this study represent cases 
of PSP.  
There is to our knowledge no large population-based epidemiological study specifically 
on PSP and its risk factors of recurrence. 
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3 Rationale, research question and hypothesis 
  
3.1 Rationale 
PSP is one of the most common chest pathologies treated by chest physicians. The main 
indication for surgery is the prevention of recurrence in high risk patients. There have 
been multiple publications reporting the experience of different medical centers, some of 
them having a significant experience. However, there are only a few rare population-
based studies on the subject, and none adequately or specifically examine the 
epidemiology, risk factors and recurrence rates for PSP. This is in part a consequence of 
the absence of specific codes differentiating primary and secondary spontaneous 
pneumothorax in the International Codification of Disease. The consequence is a 
variability between the recommendations of the different thoracic societies, and an 
important non-adherence to national guidelines of treatments.4,15,44  We conducted this 
work with the hope to provide researchers with a tool to facilitate large population-based 
studies on PSP. 
 
3.2 Research question and hypothesis 
The objective of this study was to create and validate an administrative data algorithm 
which would allow the identification of PSP cases from the recorded emergency room 
and hospital administrative data. We hypothesized that we could build an algorithm 
identifying PSP cases with a sensitivity and positive predictive value of at least 80%, to 
be used in large population-based study. 
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4 Methods 
 
4.1 Study design 
We performed a retrospective validation study to assess the accuracy of an algorithm 
designed to identify cases of PSP amongst patients presenting to the emergency room 
with a main diagnosis of pneumothorax. The results obtained from the proposed 
algorithm were compared to the reference standard obtained from manual chart review. 
The research protocol was reviewed and approved by the Health Sciences Research 
Ethics Board at the University of Western Ontario (00000940-105409).   
 
4.2 Creation of the algorithm 
The development of the algorithm was based on the same concepts used clinically to 
differentiate between PSP and other types of pneumothorax. It was derived from clinical 
reasoning and designed following discussions amongst the research collaborators after a 
complete review of the ICD-10-CA codes to identify the different clinical entities that are 
recognized to be a cause of SP. Four main diagnostic codes of pneumothorax were 
chosen as algorithm inclusion criteria because they were potentially associated with 
patients presenting PSP. These codes were included the following: 
- J93.0 Spontaneous tension pneumothorax 
- J93.1 Other spontaneous pneumothorax 
- J93.8 Other pneumothorax 
- J93.9 Pneumothorax, unspecified 
We decided not to include some additional diagnosis of pneumothorax found in the ICD-
10-CA in our algorithm, as they likely represented cases of secondary, iatrogenic or 
traumatic pneumothorax. Those unused codes were:  
- congenital or perinatal pneumothorax (P25.1) 
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- postprocedural pneumothorax (J95.811) 
- traumatic pneumothorax (S27.0) 
- tuberculous pneumothorax (A15) 
- pyopneumothorax (J86) 
The next step in the algorithm creation was the exclusion of all cases not believed to be 
related to PSP and representing potentially either an iatrogenic pneumothorax, a 
secondary pneumothorax consecutive to a chronic condition, or a pneumothorax related 
to an acute illness or event such as trauma, pneumonia, status asthmaticus, etc. Below are 
the details of the three steps of algorithmic exclusion: 
 
1. Patients with a hospital admission record in Discharge Abstract Database (DAD) 
in the previous 30 days were excluded unless their main diagnosis was pneumothorax, as 
they could represent cases of iatrogenic pneumothorax from a procedure or an 
intervention having occurred during this hospitalization. 
2. Patients with a chronic condition associated with SP where excluded. We 
identified these patients based on all diagnosis in DAD and National Ambulatory Care 
Reporting System (NACRS) databases recorded for 14 conditions present at the index 
emergency room visit date, or earlier. (Table 1.) 
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Table 1. Chronic conditions identified as potential cause of secondary 
pneumothorax with corresponding ICD-10-CA codes. 
 
 
3. We also excluded the patients presenting with an acute condition potentially 
causing SP in the 30-days prior to the first visit for PSP. (Table 2.) 
For each patient all information from index date and previous visits DAD and NACRS 
recorded locally were obtained.  The information collected for the analysis included the 
admission and discharge dates and all ICD-10-CA diagnostic codes.  The data from the 
different visits and databases were pooled for each individual and submitted to the 
algorithm. 
 
 
 
 
Chronic conditions
Chronic Obstructive Pulmonary disease J40, J410, J411, J418, J42, J431,432, J438-J441, J961, J982
Thoracic endometriosis N808
Pneumocystis B59
Sarcoidosis D860-J863, D868,D869
Tuberous sclerosis Q851
Rheumatoid arthritis M051-M053, M058-M060, M062-M064, M068, M069, M080
Ankylosing spondylitis M081, M45
Scleroderma L940-L941
Ehler-Danlos syndrome Q796
Marfan syndrome Q874
Langerhan's disease D760, D763
Cystic fibrosis E840, D841, D848, D849
Interstitial lung disease J841, J848, J849
Lung neoplasm C3400, C3401, C3409-C3411, C3419, C342, C3430, C3431, C3439, C3480, C3481,
C3489, C3490, C3491, C3499, C780, C783, D022, D023, D024, D174, D143, D381
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Table 2. Acute conditions identified as potential cause of secondary pneumothorax 
with corresponding ICD-10-CA codes. 
 
 
4.3 Validation study cohort creation 
 
The charts of the first 150 consecutive patients who presented at the LHSC Victoria 
Hospital from January 2003 to March 2010 with a main ICD-10-CA diagnosis of 
pneumothorax were considered for inclusion in the study. The sample size estimation is 
detailed at chapter 4.7. The patient`s charts where identified from the NACRS database 
information stored locally at the hospital’s Medical Records service. The NACRS 
database contains data for hospital-based ambulatory care and is mandatory in Ontario for 
all day surgery and emergency department visits. It includes the recording of the main 
diagnosis along with up to 25 additional ICD-10-CA diagnostic codes collected from 
trained abstractors. In this study, patient’s recruitment was limited to individuals aged at 
the time of consultation between 18 and 65 years, representing an age distribution that 
Acute conditions
Chest trauma S202-S204, S207, S208, S2100, S2101, S2110, S2111, S2120, S2121, S2170, S2171,
 S2180, S2181, S2190, S2191, S22000, S22001, S22010, S22011, S22090, S22091, 
S22100, S22101, S22200, S22201, S22300, S22301, S22400, S22401, S22410,
 S22411, S22490, S22491, S22500, S22501, S22800, S22900, S230-S235, S240,
 S2410-S2413, S2418-S2420, S2428, S2438, S2440, S2448, S2458, S2468,
 S250-S255, S257-S259, S26000, S26001, S26800, S26801, S26810, S26811, S26880,
 S26881, S26890, S26891, S27000, S27001, S27100, S27101, S27200, S27201,
 S27300, S27301, S27310, S27311, S27380, S27381, S27390, S27391, S27400,
 S27410, S27480, S27490, S27500, S27510, S27511, S27580, S27590, S27600, 
S27601, S27610, S27611, S27680, S27690, S27700, S27701, S27710, S27711,
 S27780, S27790, S27791, S27800, S27801, S27810, S27811, S27840, S27841,
 S27850, S27851, S27860, S27861, S27890, S27891, S27900, S27901, S27980,
 S27981, S280, S281, S2900, S2908, S297-S299, T001, T008-T011, T0180, T0181, 
T0190, T0191, T0210, T0211, T0270, T0271, T0280, T0281, T0290, T0291, T031,
 T039, T041, T047, T048, T049, T058-T065, T068, T07, T080, T081, T090, T091, T095,
 T098, T099, T140-T149, T792, T797, T798, T799
Foreign bodies T173-T175, T178, T179, T181, T188, T189
Status asthmaticus J4501, J4511, J4581, J4591
Pneumonia J120-J123, J128, J129, J13, J14, J150-J160, J168, J180-J182, J188, J189
Lung abscess J850-J852
26 
 
would allow the recruitment of a sufficient number of both primary and secondary 
pneumothoraxes while excluding the pediatric population. The cases of pneumothorax 
were identified from one of the NACRS main diagnosis codes: J930 (spontaneous tension 
pneumothorax), J931 (other spontaneous pneumothorax), J938 (other pneumothorax), or 
J939 (pneumothorax, unspecified), correlating to the inclusion criteria of the proposed 
algorithm. These codes included the complete range of disease severity.  
For this study, it was decided to perform the validation from a group of patients having 
one of the ICD-10-CA codes of pneumothorax. It would have been difficult to recruit 
enough patients having a PSP from a wider inclusion characteristic such as the presence 
of shortness of breath or pleuritic chest pain at presentation. But because the goal of the 
algorithm was to differentiate PSP cases from other types of pneumothorax, and because 
of the high accuracy of the J93 code, the cohort was built from patients diagnosed at the 
emergency with a diagnosis of pneumothorax. 
 
4.4 Reference standard 
To define the validity of the propose algorithm, the results needed to be compared to a 
reference standard obtained by manual chart review.  Patient charts were abstracted by 
two independent physicians, blinded to the recorded administrative data coding (KG, 
AS).  The reviewers confirmed or rejected the diagnosis of pneumothorax from the 
documents contained in the charts, including the radiology reports and images if needed.  
All cases of pneumothorax were defined as PSP or SP.  Where there was disagreement 
between reviewers, the diagnosis was obtained following a review by a third physician 
(EF). 
 
4.5 Statistical methods 
The results obtained from the algorithm and from the chart review were compared.  The 
results were stratified over two age groups, patients under 40 years-old, and patients 40 
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years or older, this threshold representing the midpoint of the usual distribution peaks for 
PSP and SP. 
The chart review results were considered as the gold standard reference for the validation 
of the proposed algorithm.  Comparing the results from the chart review and 
administrative data algorithm, sensitivity, specificity, positive predictive value (PPV), 
and negative predictive value (NPV) were calculated, including the 95% confidence 
interval.  SAS software version 9.3 was used.  Fisher’s exact test was used to compare 
categorical data of the two patients groups including sensitivity, specificity, PPV and 
NPV. The kappa statistic was calculated as a measure of agreement between reviewers’ 
results.  Additional calculations of sensitivity and specificity were performed to evaluate 
the ability of the algorithm to define PSP when limiting the diagnosis to patients below 
different age thresholds set between 30 and 50 years of age. 
In this study, sensitivity was defined as the proportion of PSP patients (identified from 
the reference standard) adequately having a positive result from the algorithm. Specificity 
as the proportion of patient without PSP from the reference standard and negative from 
the algorithm. PPV was the proportion of algorithm positive patients truly having PSP 
from the reference standard, and NPV was the proportion of algorithm negative patients 
not having a PSP from the reference standard. 
 
4.6 Sample size calculation 
 
To evaluate the diagnostic performance of the proposed algorithm to diagnose primary 
pneumothoraxes, sensitivity and specificity was obtained from a comparison to the 
reference standard, taken from manual chart review.  The necessary sample size has been 
calculated following the binomial exact approach for a dichotomous diagnostic test using 
the SAS 9.3 software (SAS Institute Inc., Cary (NC) USA). A significance level of 0.05 
has been chosen to calculate the total number of patients necessary to reach a power of 
90% in a non-inferiority trial, comparing the proposed algorithm binomial results to a 
standard reference obtained from manual chart review, using a one-sided exact test with 
expected sensitivity and specificity of 90% and minimal acceptable sensitivity and 
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specificity of 80%.  As shown in Figure 5, because of the nature of the binomial 
distribution, a “saw-toothed” curve was acquired when power was expressed for different 
values of sample size. This phenomenon was expected as previously described.45 From a 
conservative analysis of this graph, it is noted that the power of the study to reject the null 
hypothesis was superior to 90% for any value of sample size superior to 130. Considering 
possible incomplete data and other challenges that might present during chart reviews, an 
additional 15% cases have been added to the number in order to reach a total sample size 
of 150 patients in this study. 
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Figure 5. Saw-tooth appearance of the graph reporting the calculated power of an 
exact test for binomial proportions in a non-inferiority study attempting to 
document a minimal acceptable sensitivity or specificity of 80% when a result of 
90% is expected. 
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5 Results 
 
5.1 Manual chart review  
Of the 150 patients included in this study, 95 were under the age of 40 years and 55 were 
aged 40 years and over.  The chart review could not identify any evidence of 
pneumothorax in the charts of 6 patients, while 96% had a pneumothorax corresponding 
appropriately to the main diagnosis.  These included 90 cases of PSP, representing 60% 
of patients.  Eighty-two percent of these (74 cases) were found in patients under 40 years-
old, while 18% were identified in older patients.   
There was an agreement of 88% between the two reviewers; corresponding to a kappa 
statistics of 0.76 and a third review was necessary in 18 cases. 
 
5.2 ICD-10-CA codes used as inclusion criteria 
The review of the administrative data revealed that the code J939 (pneumothorax, 
unspecified) was the most commonly used to describe the main diagnosis, present in 85 
of the 150 patients. However in younger patients, the code J931 (other spontaneous 
pneumothorax) was also commonly used and was identified in 48% of the 95 patients. 
The codes J930 (spontaneous tension pneumothorax) and J938 (other pneumothorax) 
were retrieved in only 4 patients for each of them.  
 
5.3 Results from the algorithm   
The reason to suspect a SP from the administrative data was most commonly related to an 
associated chronic condition which could be identify in 23 of the 39 patients not 
considered to have a PSP from the results of the algorithm. In some patients, more than 
one potential cause of secondary pneumothorax was identified.  These results are detailed 
in Table 3. 
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Table 3. Distribution of patients with a main diagnosis code of pneumothorax 
according to age group. 
 
 
The ability of the proposed algorithm to identify cases of PSP is detailed in Table 4, 
which summarizes diagnostic accuracy.  Overall, sensitivity of the algorithm for PSP was 
94%, being higher in younger patients (97%) than in older patients (81%), p=0.0376.  
Similarly, a higher PPV was obtained when the algorithm was applied to the younger 
patients population, 87%, compared to 46% for the patients ages 40 years or more 
(p<0.0001).  The overall specificity of the algorithm was 57%, and no significant 
difference was identified between the younger and older patient groups.  Similarly, there 
was no significant difference between the two groups NPVs, the overall value estimated 
to 87%.  
0 to 39 years 40 years and over Total
Number of patients 95 55 150
main diagnosis code
J930 2 2 4
J931 46 11 57
J938 2 2 4
J939 45 40 85
clinical review
primary spontaneous pneumothorax 74 16 90
secondary pneumothorax 17 37 54
absence of pneumothorax 4 2 6
administrative data algorithm
primary spontaneous pneumothorax 83 28 111
secondary pneumothorax 12 27 39
suspected etiology:
chronic condition 5 18 23
acute condition 7 6 13
iatrogenic 3 10 13
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Table 4. Diagnostic performance of the administrative data algorithm for the 
identification of primary spontaneous pneumothorax cases (estimate and 95% 
confidence interval). 
Measure Total 
0 to 39 years 
40 years and 
over 
p 
Sensitivity 94 (88 - 98)   97 (91 - >99) 81 (54 - 96)   .0376 
Specificity 57 (43 - 69) 48 (26 - 70) 62 (45 - 77)   .4135 
Positive predictive value 77 (68 - 84) 87 (78 - 93) 46 (28 - 66) <.0001 
Negative predictive 
value 
87 (73 - 96) 83 (52 - 98) 89 (71 - 98)   .6342 
 
 
5.4 Age dichotomization cutting point  
In order to evaluate the appropriateness of the 40-years threshold used in the study, we 
performed additional modifications on the algorithm for different age levels varying 
between 30 and 50 years.  We calculated the sensitivity and specificity of the algorithm 
applied to the 150 patients when limiting the diagnosis of PSP to patients younger than 
each age point. Between the levels of 30 to 50 years, the sensitivity varied from 59% to 
88% and the specificity from 82% to 63% (Figure 6).  
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Figure 6. Sensitivity and specificity of the algorithm’s modifications applied to the 
150 patients and restricting the diagnosis of primary spontaneous pneumothorax to 
patients below the age level detailed on the axis. 
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6 Discussion 
 
6.1 Importance of differentiating PSP from SP 
PSP is by definition a spontaneous and unprovoked event usually occurring in young and 
previously healthy individuals.  It differs from SP, which represents a proportion of about 
half of all pneumothorax.3,46-48 All pneumothorax will require similar initial management; 
however, once urgent treatment is completed, the care given to patients presenting with 
either PSP or SP will differ.49,50 Treatment of the underlying cause of SP will be 
necessary and could include chest wall stabilization, optimization of the COPD or asthma 
medication, and antimicrobial treatment of pneumonia or lung abscess.  For PSP, aside 
from smoking cessation and recommendation to avoid certain activities, most individuals 
will require no further treatment, but surgery could be offered to patients who are at a 
higher risk of recurrence or complications.4,8,15  
 
6.2 Need for epidemiological studies on PSP 
There is a need for large epidemiological studies on the subject of PSP to help define 
predictors of recurrence and lead to treatment recommendation tailored to this otherwise 
healthy and potentially productive population.  Population-based studies from United 
Kingdom and France have been published in the last few years and have produced 
significant knowledge on the subject; however, these included both primary and SP.  
Hallifax and Rahman noted an unexpectedly low proportion of SP (14%) in a report from 
the French national healthcare database, which has not been fully explained and suggests 
that a proportion of the cases might not be classified appropriately.6,51 In the present 
review, 54 patients presented with a SP, representing 38% of cases. 
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6.3 Limitations of the ICD-10-CA classification 
The 10th version of the ICD, used in Canada as in many other jurisdictions, does not 
include a sub-classification allowing the identification of the different types of 
spontaneous pneumothorax.  This situation is problematic and limits the ability of 
researchers to target PSP specifically. In the United States, a different version of the ICD 
has been implemented in October 2015, ICD-10-CM (Clinical Modification), which 
includes a subdivision of the J931 code corresponding to PSP:  J9311.52 However, it is 
difficult to anticipate the effect of this sub-classification on eventual epidemiological 
studies because of the presence of three other J93 codes which could be used for PSP.  In 
our study, only 38% of patients were coded J931, the majority (57%) of the charts were 
labeled with the code J939 (pneumothorax, unspecified). 
 
6.4 Validation of administrative data  
Code-validation is necessary before conducting population-based studies to ensure 
adequacy of the patient cohorts.53 In Canada, the Institute for Clinical Evaluative 
Sciences (ICES) reported in 2006 that the pneumothorax code J93 is amongst the most 
accurately used (95%) of the main diagnosis codes, and this correlates to the results of 
this review which identified a miscode rate of only 4%.42 However, to our knowledge, 
this study represents the first attempt to differentiate between PSP and SP using hospital 
administrative data.  Defining PSP by only the absence of associated codes for underlying 
lung disease was not considered sufficient in the design of this study and three exclusion 
criteria were created with the goal of obtaining a better case definition.  Based on the 
results of the administrative data algorithm, these exclusion criteria identified a 
significant proportion of patients experiencing SP, particularly in younger patients for 
which the presence of a chronic condition was responsible for only 42% of cases defined 
as SP. 
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6.5 Study strengths and limitations 
PSP is known to occur in a younger population than SP, and multiple studies have 
suggested that peak incidence occurs between 20 and 30 years of age.  When creating the 
inclusion criteria for a population-based study oriented towards this age group, an option 
would be to use the patient`s age to minimize the number of misdiagnoses that would be 
associated with inclusion of older patients.  This study’s dichotomization of younger 
versus older patients allowed observation of the effect of this strategy.  The ability of the 
proposed algorithm to accurately identify cases of PSP cases was significantly better 
when limited to the younger group of patients.  However, using this method would 
exclude cases of true PSP occurring in older patients (16 individuals in this study) and 
limit the participation to about 82% of potential patients. However, these individuals 
might also have a non-diagnosed underlying lung condition. 
The proposed algorithm demonstrated a good diagnostic accuracy in defining PSP cases 
amongst patients under 40 years of age.  The 97% sensitivity rate found in this age group 
suggests that almost all PSP cases can be identified with the use of administrative data.  
And, as demonstrated by the 87% PPV, the identification of a PSP case from the 
algorithm will be correct in a very high proportion of patients.  These findings also 
suggest that limiting the diagnosis of PSP to the absence of recorded concurrent lung 
conditions might be insufficient and could be improved by the use of more restrictive 
exclusion criteria. 
The limitations of the proposed algorithm are related to its lower than expected 
specificity.  This is a direct consequence of a high number of patients falsely considered 
to have a PSP, particularly in the older population.  This suggests either that the strict 
criteria used in this study for PSP definition might not be sufficient or more likely, that 
the recording of secondary diagnosis into NACRS and DAD databases is occasionally 
incomplete.  Thus, it would be prudent to limit the use of the algorithm to the suggested 
target population of PSP, as its accuracy might be insufficient when attempting to build a 
cohort of patients with SP. 
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Choosing an appropriate reference standard is an important part of a validation study. The 
“golden” standard used in this study was based on the review of patients charts by two 
independent reviewers. Even if the patients were not directly evaluated by the reviewing 
physicians, the ability to proceed with a third chart review in cases of non-agreement is 
thought to have provided this study with a solid reference standard. 
6.6 Future direction 
The findings of this study support the use of the proposed algorithm as an appropriate 
method of PSP identification for the conduction of population-based epidemiological 
studies based on administrative data using ICD-10 codes.  As a result, an ICES study 
proposal abstract has been written. It proposes the use of this study’s algorithm to 
evaluate in the population of Ontario the epidemiology of PSP and its recurrence factors 
(Appendix A). Because of the wide acceptance of the ICD-10 codification system, it is 
possible that the proposed algorithm could be exported to other provincial and national 
databases even if discharged summaries slightly different than DAD or NACRS could 
exist in other jurisdictions. Eventually, a clinical algorithm for the management of PSP 
might be created. In the development of such prognostic models, the process of 
derivation is different than the validation: it will allow the identification of prognostic 
factor according to a subset of patient from regression analysis. The prognostic model 
obtained needs then to be validated to ensure its external validity, often using a second 
subset of the studied population. Such clinical algorithms may have a significant impact 
on the clinical practice. 
6.7 Conclusions 
PSP is a clinical entity distinct from SP for which there is a paucity of epidemiological 
studies.  The ICD-10 codes used in most countries do not allow its direct identification.  
An algorithm was created, which uses the information available in NACRS and DAD to 
overcome this deficiency.  Of 150 patients presenting with a diagnosis of pneumothorax, 
we validated this algorithm to have a sensitivity of 97% and a PPV of 87% when used in 
a population of young patients known to be at higher risk of developing a PSP.  These 
results support the use of administrative data to identify patients consulting for PSP and 
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give researchers the tools required to conduct epidemiological studies on large 
population-based data.  Such studies are expected to improve the understanding of the 
disease, its treatment and related outcomes. 
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Appendix A 
Proposed ICES study abstract 
 
Title: Risk of recurrence of primary spontaneous pneumothorax in 
Ontario: a retrospective population-based cohort study. 
Short title: Recurrence of primary spontaneous pneumothorax 
Investigators: Eric Fréchette, Ester Lau, Marcus Povitz, Yun-Hee Choi Blayne Welk, 
Richard Malthaner 
 
Background:  
Primary spontaneous pneumothorax (PSP) is a common thoracic disorder having a peak of 
occurrence present between the ages of 20 and 30 years and affecting previously healthy 
individuals.1,2  The definitive treatment is surgical and is directed at preventing recurrence 
in high-risk patients.3 Many risk factors for recurrence have been identified in case series, 
however, in part because of an inadequate coding in the international classification of 
disease (ICD-10), there is no large population-based study from administrative data 
directed specifically at the study of the recurrence after an episode of PSP.4,5 The result 
from this situation is that it is often difficult to predict adequately the risk of recurrence in 
these patients and to suggest the most appropriate treatment. This is depicted with the 
conflicting recommendations from different thoracic societies on PSP and the weak 
adherence of the caregivers to those recommendations.6-8 An algorithm allowing the 
identification of PSP cases from administrative data was recently developed and validated, 
but was never used to define the risk of PSP recurrence at the population level.9 
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Project objectives:  
1. To define the factors associated to PSP recurrence in patients presenting with a 
previous episode in Ontario; 
2. To define the impact of PSP recurrence on the utilization of health services and on 
the associated cost for the healthcare system. 
 
 
Methods: 
  A population-based, retrospective cohort study will be conducted from the databases 
stored at the Institute for Clinical Evaluative Sciences (ICES).  Patients 18-39 years old 
presenting with a first episode of PSP between April 1, 2004 and March 31, 2014 will be 
included in the study. The PSP cases will be identified from the ICD-10 codes J930, J931, 
J938 and J939 recorded as main diagnosis of emergency room summary National 
Ambulatory Care Reporting System (NACRS).  A look-back period extending to April 1, 
1992 will be used to rule out any previous pneumothorax episodes and will include a two-
year period of ICD-10 diagnosis codes collection from NACRS and Discharge Abstract 
Database (DAD) which will be processed by an algorithm previously described to exclude 
cases suspected to be secondary, iatrogenic or traumatic pneumothorax. The other 
exclusion criteria will include a missing age, sex, and patients residing outside Ontario at 
the time of index event. The maximum follow-up period will extend to March 31, 2016. 
The consulted databases will include the Registered Person Database (RPDB), the Ontario 
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Health Insurance Plan Claims Database (OHIP), DAD, NACRS, and the following 
databases: SDS, ODB, IPDB, CENSUS, POP, PCCF, LHIN, INST, OMHRS, CCRS/NRS, 
OHCAS/HCD, and ADP. The main outcome will be the development of another episode 
of pneumothorax recorded as main diagnosis in NACRS or DAD. The patients will stay 
included in the cohort following an event of pneumothorax recurrence to allow the analysis 
of the impact of the number of previous episodes on the outcome. The exposure 
characteristics analysed in this study will include patient sex, age at time if index event, 
number of previous episodes, type of initial treatment (chest drainage, pleurodesis, 
surgery), need for hospitalization, duration of initial hospitalization, specialty of the 
physicians involved, type of institution initially visited and mean neighborhood income. 
The cost estimation will be obtained using the %GETCOST macro. 
The risk of recurrence will be studied using time-to-event analysis. Recurrence rate at 2 
and 5 years will be estimated using the Kaplan Meier technique. The influence of the 
different risk factors on recurrence will be calculated using multivariable Cox proportional 
hazard regression analysis for multiple events. As the patients could not be at risk of a 
second recurrence before having developed a first one, a conditional model “A” will be 
used; the time interval for the second recurrence will be measured from the time of 
occurrence of the first one.  
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Expected cohort size and number of events: 
 The ICES NACRS EDMAINPROBLEM data informed us that there were 27880 
emergency room visits recorded in the NACRS database with a main diagnosis code J930, 
J931, J938 or J939 during the 10-year period starting in year 2004. From the information 
collected in our validation study, we expect that the algorithm will identify 55% of those 
cases as PSP occurring in individuals aged between 18 and 39 years old. This represents 
more than 15,000 cases of PSP. The expected proportion of recurrent events is thought to 
be about 30-40%. 
  
Relevance: 
This project has the potential to significantly improve health care delivery. It will be the 
first large population-based study on PSP and its recurrence. It will offer physicians and 
other health care providers an understanding of the risk of recurrence according to the 
number of previous episodes and other patients’ clinical characteristics. This study will 
define for the first time the impact of PSP recurrence in term of costs for the health care 
system. This information might help defining the indications for surgery or other treatments 
according the expected need for additional treatments and associated costs.  
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Appendix E 
 
Chart review collected results 
 
(Legend: 1= primary spontaneous pneumothorax, 2=Secondary pneumothorax, 
3= no pneumothorax, revres= review result for analysis) 
 
Study ID Reviewer 
1 
Reviewer 
2 
Reviewer 
3 
revres 
 
agreement 
1 1 1 . 1  1 
2 1 1 . 1  1    
3 2 2 . 2  1    
4 2 2 . 2  1    
5 1 1 . 1  1    
6 1 1 . 1  1    
7 2 2 . 2  1    
8 2 3 2 2  0    
9 1 1 . 1  1    
10 2 2 . 2  1    
11 1 1 . 1  1    
12 2 1 1 1  0    
13 2 2 . 2  1    
14 1 1 . 1  1    
15 2 2 . 2  1    
16 2 2 . 2  1    
17 2 2 . 2  1    
18 2 1 2 2  0    
19 1 1 . 1  1    
20 1 1 . 1  1    
21 2 2 . 2  1    
22 1 1 . 1  1    
23 1 1 . 1  1    
24 1 1 . 1  1    
25 1 1 . 1  1    
26 1 1 . 1  1    
27 2 2 . 2  1    
28 2 2 . 2  1    
29 1 1 . 1  1    
30 2 2 . 2  1    
31 1 1 . 1  1    
32 3 3 3 3  1    
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33 2 2 . 2  1    
34 1 1 . 1  1    
35 2 1 1 1  0    
36 1 1 . 1  1    
37 2 2 . 2  1    
38 2 2 . 2  1    
39 2 2 . 2  1    
40 1 1 . 1  1    
41 1 1 . 1  1    
42 1 1 . 1  1    
43 2 2 . 2  1    
44 2 2 . 2  1    
45 1 1 . 1  1    
46 1 1 . 1  1    
47 1 2 1 1  0    
48 2 2 . 2  1    
49 3 3 . 3  1    
50 2 2 . 2  1    
51 3 3 . 3  1    
52 2 2 . 2  1    
53 1 1 . 1  1    
54 1 1 . 1  1    
55 1 3 3 3  0    
56 1 2 1 1  0    
57 1 1 . 1  1    
58 1 1 . 1  1    
59 1 1 . 1  1    
60 1 1 . 1  1    
61 1 1 . 1  1    
62 1 1 . 1  1    
63 3 2 2 2  0    
64 1 1 1 1  1    
65 1 1 . 1  1    
66 1 1 . 1  1    
67 1 1 . 1  1    
68 2 2 . 2  1    
69 2 2 . 2  1    
70 2 2 . 2  1    
71 1 1 . 1  1    
72 1 1 . 1  1    
73 1 1 . 1  1    
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74 1 1 . 1  1    
75 1 1 . 1  1    
76 1 1 . 1  1    
77 2 2 . 2  1    
78 1 1 . 1  1    
79 2 2 . 2  1    
80 2 2 . 2  1    
81 2 3 3 3  0    
82 1 1 . 1  1    
83 2 2 . 2  1    
84 2 1 2 2  0    
85 1 2 2 2  0    
86 1 2 2 2  0    
87 2 2 . 2  1    
88 1 1 . 1  1    
89 1 1 . 1  1    
90 1 1 . 1  1    
91 1 1 . 1  1    
92 2 2 . 2  1    
93 1 1 . 1  1    
94 3 2 2 2  0    
95 1 1 . 1  1    
96 2 2 . 2  1    
97 2 2 . 2  1    
98 1 1 . 1  1    
99 1 1 . 1  1    
100 1 3 3 3  0    
101 1 1 . 1  1    
102 1 1 . 1  1    
103 1 1 . 1  1    
104 1 1 . 1  1    
105 1 1 . 1  1    
106 1 1 . 1  1    
107 1 1 . 1  1    
108 2 1 2 2  0    
109 2 2 . 2  1    
110 2 1 1 1  0    
111 2 2 . 2  1    
112 2 2 . 2  1    
113 1 1 . 1  1    
114 1 2 2 2  0    
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115 1 1 . 1  1    
116 1 1 . 1  1    
117 1 1 . 1  1    
118 1 1 . 1  1    
119 1 1 . 1  1    
120 1 1 . 1  1    
121 2 2 . 2  1    
122 2 2 . 2  1    
123 2 2 . 2  1    
124 1 1 . 1  1    
125 1 1 . 1  1    
126 1 1 . 1  1    
127 1 1 . 1  1    
128 1 1 . 1  1    
129 1 2 1 1  0    
130 1 1 . 1  1    
131 1 1 . 1  1    
132 1 1 . 1  1    
133 1 1 . 1  1    
134 1 1 . 1  1    
135 2 2 . 2  1    
136 2 2 . 2  1    
137 2 2 . 2  1    
138 1 1 . 1  1    
139 1 1 . 1  1    
140 2 2 . 2  1    
141 1 1 . 1  1    
142 2 2 . 2  1    
143 2 2 . 2  1    
144 1 1 . 1  1    
145 1 1 . 1  1    
146 1 1 . 1  1    
147 2 2 . 2  1    
148 1 1 . 1  1    
149 1 1 . 1  1    
150 1 1 . 1  1    
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